Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
09/2002
09/06/2002WO2002068367A1 A method to inhibit ethylene responses in plants
09/06/2002WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/06/2002WO2002067851A2 Method for treating fibrotic diseases or other indications iiic
09/06/2002WO2002067761A2 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
09/06/2002WO2002043648A8 Compounds active at the glucocorticoid receptor ii
09/06/2002WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance
09/06/2002WO2002030558A3 A linker and a method of chemical synthesis
09/06/2002WO2002030405A3 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
09/06/2002WO2001090071A3 Substituted iminoazines used as herbicides
09/06/2002CA2438828A1 Aryl carbamate derivatives, preparation and use thereof
09/06/2002CA2438174A1 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
09/06/2002CA2434666A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
09/06/2002CA2433425A1 Method for treating fibrotic diseases or other indications iiic
09/05/2002US20020123633 Reacting an alpha -picoline or gamma -picoline with formaldehyde in vapor phase in presence of metal cation modified zeolite MFI or zeolite zeolite MEL to produce 2-vinylpyridine or 4-vinylpyridine compound
09/05/2002US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker
09/05/2002US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC
09/05/2002US20020123521 Such as triiodothyroacetic acid, triiodopropionic acid, 4-(2,6-dibromo-4-(1H-tetrazol-5-ylmethyl)-phenoxy)-2-isopropyl-phenol, and 4-(4-hydroxymethyl-2,6-diiodophenoxy)-2-iodo-phenol
09/05/2002US20020123498 For inhibiting transport protein; therapy
09/05/2002US20020123496 Novel pyridazine derivatives and medicines containing the same as effective ingredients
09/05/2002US20020123495 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death
09/05/2002US20020123493 For therapy and prophylaxis of neuronal damage
09/05/2002US20020123492 Beta-amino acid derivatives
09/05/2002US20020121638 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
09/05/2002DE10110325A1 Phenylderivate 2 Phenyl derivatives 2
09/04/2002EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof
09/04/2002EP1236717A1 Oxime o-ether compounds and fungicides for agricultural and horticultural use
09/04/2002EP1236712A1 Amidinophenylpyruvic acid derivative
09/04/2002EP1235824A1 Vitamin d analogues
09/04/2002EP1235807A1 B-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa
09/04/2002EP1235805A2 Immunoassay for neonicotinyl insecticides
09/04/2002EP1235788A1 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties
09/04/2002EP1235777A2 Vitamin d analogues
09/04/2002EP1235575A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
09/04/2002EP1080086B1 Dihydropyrimidines
09/04/2002EP0889878B1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors
09/04/2002EP0635008B1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors
09/04/2002CN1367687A Calcilytic compounds
09/04/2002CN1090182C Process for preparation of 5-substituted 2-chloropyridines
09/04/2002CN1090177C Preparation of aromatic nitriles
09/04/2002CN1090176C Purification of nitrile
09/04/2002CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds
09/04/2002CN1090019C 组合物 The composition
09/03/2002US6444820 Process for the manufacture of camptothecin derivatives
09/03/2002US6444817 Anticoagulants
09/03/2002US6444815 Method for producing heteroaromatic aldehydes
09/03/2002US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/03/2002US6444691 1,3-disubstituted ureas as ACAT inhibitors, and method of preparing thereof
09/03/2002US6444606 Supported catalyst system, method for the production and use thereof in olefin polymerization
09/03/2002US6444279 Liquid crystal propene or propenyl nitrile derivatives
09/01/2002CA2373578A1 .beta.3, agonists and uses thereof
08/2002
08/29/2002WO2002067053A2 High speed photothermographic materials containing tellurium compounds and methods of using same
08/29/2002WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists
08/29/2002WO2002066470A1 Substituted alkylamine derivatives and methods of use
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066434A1 Oxime ether compound and agricultural or horticultural bactericide
08/29/2002WO2002066433A1 Process and catalyst for the preparation of acetylpyridines
08/29/2002WO2002066432A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
08/29/2002WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/29/2002WO2002066430A1 Tryptase inhibitors
08/29/2002WO2002066425A2 Compositions and methods for hydration of terminal alkynes
08/29/2002WO2002066420A2 Tryptase inhibitors
08/29/2002WO2002066418A2 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
08/29/2002WO2002066416A1 Method of synthesizing camptothecin-relating compounds
08/29/2002WO2002066413A1 Flecainide synthesis
08/29/2002WO2002066020A2 Modulation of gsk-3beta activity and its different uses
08/29/2002WO2002065977A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
08/29/2002WO2002042273A3 Acid derivatives useful as serine protease inhibitors
08/29/2002WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/29/2002WO2001087288A8 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
08/29/2002WO2001017530A9 Iron chelators and uses thereof
08/29/2002WO2001012584A3 Pharmaceutical compounds
08/29/2002WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof
08/29/2002WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
08/29/2002US20020120147 Micronized torsemide
08/29/2002US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
08/29/2002US20020120007 Benzamide inhibitors of factor Xa
08/29/2002US20020119979 Cancer therapy
08/29/2002US20020119968 Protease inhibitor
08/29/2002US20020119960 Drug resistance therapy
08/29/2002US20020119957 Novel post-amadori inhibitors of advanced glycation reactions
08/29/2002US20020119955 Modified prodrug forms of AP/AMP
08/29/2002US20020119953 Sickle cell anemia
08/29/2002US20020119910 Drug delivery
08/29/2002DE19941540C2 Sulfonylcarboxamide zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidämie Sulfonylcarboxamide for the preparation of medicaments for the prophylaxis or treatment of hyperlipidemia
08/29/2002DE10108307A1 Substituierte Propan-1,3-diamin-Derivate Substituted propane-1,3-diamine derivatives
08/29/2002CA2683768A1 Method of synthesizing camptothecin-relating compounds
08/29/2002CA2439898A1 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
08/29/2002CA2438711A1 Tryptase inhibitors
08/29/2002CA2438685A1 Tryptase inhibitors
08/29/2002CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2437704A1 Process and catalyst for the preparation of acetylpyridines
08/29/2002CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists
08/29/2002CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/28/2002EP1234827A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234826A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234825A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1234824A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation